774,194 Shares Cidara Therapeutics, Inc. Series X Preferred Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 8th, 2021 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 8th, 2021 Company Industry Jurisdiction